Newsroom

Fierce Biotech I After 3 years away, BIO marked by first-time handshakes

Written by Max Bayer June 15, 2022 Six days after the World Health Organization officially declared COVID-19 a global pandemic on March...

BioSpectrum Asia I Our approach to managing the side effects of cancer therapy has evolved

Source: https://www.biospectrumasia.com/e-magazine By Dr. Manbeena Chawla June 2022 Although there has been tremendous progress in...

OnQuality Pharmaceuticals to Have Two Abstracts Published in the 2022 ASCO Annual Meeting Proceeding

View on PRNewswire - Preclinical data demonstrating OQL051, a gut-restricted CDK4/6 inhibitor, as a potential prophylactic treatment for...

Podcast: Leading without the Title: Becoming a Natural Leader – with Hong Tang

Source: https://brilliancewithincoaching.com/podcast/leading-without-the-title-becoming-a-natural-leader-with-hong-tang/ Hong Tang is the...

OnQuality Pharmaceuticals to Present Preclinical Data for OQL051, a Novel CID Therapeutic, at AACR

- OnQuality will present preclinical data demonstrating OQL051, a gut-restricted CDK4/6 inhibitor, as a potential prophylactic treatment...

Informa I Scrip Asks…What Does 2022 Hold For Biopharma? Part 4: Therapeutic Area Advances

High Hopes In COVID-19, Cancer, CNS, Immunology And Rare Disease By Eleanor Malone March 1, 2022 Executive Summary Evolving challenges...

OnQuality Pharmaceuticals to Present NOVA-II Phase 2 Trial Update and Oncologist Survey at ASCO GU

- OnQuality will present an update on its NOVA-II Phase 2 clinical trial investigating OQL011, a proprietary ointment designed to treat...

GEN | Supportive Care: OnQuality Treats Cancer’s Side Effects

Written by Alex Philippidis February 2, 2022 OnQuality recently announced positive news for its lead candidate OQL011, an ointment...

Life Science Leader | The Key To Competitive Differentiation In Life Sciences Is People

Written by Michael McCullar, Ph.D. Feb. 1, 2022 The ability to differentiate in a competitive marketplace lies in developing key...

OnQuality Pharmaceuticals to Present Oncologist Survey Data Demonstrating Need for [...]

Full Title: OnQuality Pharmaceuticals to Present Oncologist Survey Data Demonstrating Need for New Cancer Therapy-Associated Diarrhea...